Erectile Dysfunction
Recovery

Bioelectric Signaling designed for
Erectile Dysfunction Recovery

Our precision signals are directed
towards controlling the release
of these natural proteins.

Erectile Dysfunction
Recovery

Bioelectric Signaling designed for
Erectile Dysfunction Recovery

Our precision signals are directed
towards controlling the release
of these natural proteins.
According to landmark studies by University of Chicago researchers, among men aged 50 to 64, about one-third suffer erectile dysfunction otherwise known as ED. From age 65 to 85, the figure is approximately 44 percent.

ErectiStim has developed a patent pending technology of precise bioelectric signaling designed for erectile dysfunction recovery. Our precision signals are directed towards controlling the release of these natural proteins.

Designed and intended to control expressions of these proteins

SDF-1 & PDGF for stem cell homing

IGF-1 & LIM for Nerve Regeneration

Follistatin & Klotho for muscle regeneration

EGF for Metabolic Syndrome Reversal

VEGF, PDGF, EGF, HIF1a, CXCL5, eNos and SDF1

for improving blood circulation

Lab experiments have demonstrated with specific signaling sequences at certain frequency ranges with selected pulse widths, pulse durations, voltage and current that these named up-regulated protein expressions can be controlled out of cells or tissues on demand. Literature review of previous peer reviewed published studies and limited internal studies indicate a trend that these protein expression MAY be useful for angiogenesis, myogenesis, elasticity improvement and nerve connection repair. This is early stage research and not all these signals and protein expressions have been validated through animal and clinical study results. Protein expression results obtained in pre-clinical studies may not translate to clinical results especially across different cell types, tissues or organs.

Increasing local blood circulation and muscle stimulation device - FDA 510K

ErectiStim Plus Lite™ MyoStim ED Biologics Clinical Study Protocol

MyoStim ED ErectiStim Endorses the SMSNA Position on Regulatory Pathway for Restorative Therapies for ED

An initial study on the effect of functional electrical stimulation in erectile dysfunction: a randomized controlled trial

ED affects approximately half of all men over age 40.

Important Papers

Click to download

MyoStim ED ErectiStimTM Bench Top Clinic Use High Fidelity
Precision Signal Stimulator

(U.S. FDA 510K K113017 cleared only for improving blood circulation, improved range of motion muscle
other labelling claims pending new 510K submission with new data)

MyoStim ED ErectiStim
at home use portable bioelectric stimulator

(not available for sale investigational use only)

The goal of ErectiStim is to end dependence on shots and pills and to affect a recovery of erectile function equivalent to what the men had in their 30’s or early 40’s.

The therapy is delivered via a comfortable conductive wrap with bioelectric stimulation delivered as little a 7 to 20 minutes every other day for 12 weeks run from the comfort of your own home.

Cristiane Carboni

Chief Scientific Officer
MyoStim ED ErectiStim

An initial study on the effect of functional electrical stimulation in erectile dysfunction: a randomized controlled trial

Worldwide more than 330 million of men suffer from ED.

German data: 19% of men are affected*
2% (aged 30 – 39 years)
10% (aged 40 – 49 years)
16% (aged 50 – 59 years)
34% (aged 60 – 69 years)
53% (aged 70 – 79 years)
*Braun et.al.
Epidemiology of erectile dysfunction: results of the Cologne Male Survey.
In: Int J Impot Res
12 (2000), Nr. 6, S. 305–11
ErectiStim TM benchtop device is cleared for…
FDA 510K K113017 FDA Market Clearance Indications of Use
Indications for Medium Frequency (Russian), Biphasic, High Volt Pulsed Current (HVPC), Interferential (4P) and Premodulated (2P3) waveforms
  • Prevention or retardation of disuse atrophy
  • Increase local blood circulation
  • Muscle re-education
  • Maintaining or increasing range of motion
  • Saved special treatment protocols for each waveform (used for ErectiStim TM treatment). 
 
  • ErectiStim TM is investigational for the specific direct treatment of erectile dysfunction.
  • ErectiStim is TM portable device is investigational at this time for all indications of use.  One a new round of pre-clinical tests are done we will file to have cleared for improving circulation, treating inflammation/pain and muscle recovery but NOT erectile dysfunction. We will file for erectile dysfunction later for both the portable and bench top with more data to file with. 
 
It is permitted to say which we should now add to the bottom of landing page language 
 
By improving circulation, reducing inflammation and treating muscle atrophy and improving muscle range of motion via 510K cleared indications of use with this device patients may exhibit some relief from the symptoms of erectile dysfunction.